Healthcare Triangle Inc

Healthcare Triangle Inc (HCTI) Financials

$0.844

+0.006 (+0.76%)At close

HCTI Revenue Streams

Healthcare Triangle Inc (HCTI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Customer engagement services, accounting for 69.8% of total sales, equivalent to $6.88M. Other significant revenue streams include Software Services and Managed Services and Support. Understanding this composition is critical for investors evaluating how HCTI navigates market cycles within the Software industry.

HCTI Profitability and Margins

Evaluating the bottom line, Healthcare Triangle Inc maintains a gross margin of 16.73%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -44.28%, while the net margin is -48.03%. These profitability ratios, combined with a Return on Equity (ROE) of -128.34%, provide a clear picture of how effectively HCTI converts its operational activities into shareholder value.

HCTI Comparative Benchmarking

In the context of the broader market, HCTI competes directly with industry leaders such as CYCU and BLIN. With a market capitalization of $13.16M, it holds a leading position in the sector. When comparing efficiency, HCTI's gross margin of 16.73% stands against CYCU's 20.14% and BLIN's 59.89%. Such benchmarking helps identify whether Healthcare Triangle Inc is trading at a premium or discount relative to its financial performance.

Healthcare Triangle Inc Financial Performance

Healthcare Triangle has shown some revenue growth, with Q2 2026 revenue at $9.19 million, a 158% increase year-over-year. However, net income remains negative, with a loss of $4.4 million in Q2 2026, and gross margin is at 22.5%, up from 13.8% in the previous quarter.

Financials

FY2026Q2
YoY:
+158.38%
9.19M
Total Revenue
FY2026Q2
YoY:
+199.56%
-4.07M
Operating Profit
FY2026Q2
YoY:
+222.73%
-4.42M
Net Income after Tax
FY2026Q2
YoY:
-95.52%
-1.57
EPS - Diluted
FY2026Q2
YoY:
-70.72%
-948.00K
Free Cash Flow
FY2026Q2
YoY:
+20.53%
16.73
Gross Profit Margin - %
FY2026Q2
-69.02
FCF Margin - %
FY2026Q2
YoY:
+24.92%
-48.03
Net Margin - %

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started